April 3 (Reuters) - Milestone Scientific Inc
* Milestone Scientific reports 10% increase in revenue for fiscal 2016
* Milestone Scientific Inc - believe still on track to receive regulatory marketing clearance in U.S. for epidural instrument in first half of 2017
* Milestone Scientific Inc - "deferred over $1 million in sales due a delayed payment in Q4, which we expect to record in 2017"
* Milestone Scientific Inc - with completion of clinical trials for epidural instrument, expect burn rate of medical subsidiary will be further reduced Source text for Eikon: Further company coverage: